1813-1093 Screening compound: 3-[4-(furan-2-carbonyl)piperazine-1-carbonyl]piperidin-2-one

1813-1093 Screening compound: 3-[4-(furan-2-carbonyl)piperazine-1-carbonyl]piperidin-2-one
1813-1093 Screening compound: 3-[4-(furan-2-carbonyl)piperazine-1-carbonyl]piperidin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound 1813-1093
3-[4-(furan-2-carbonyl)piperazine-1-carbonyl]piperidin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

1813-1093

Molecular Formula

C15H19N3O4 (C15 H19 N3 O4)

Compound Name

3-[4-(furan-2-carbonyl)piperazine-1-carbonyl]piperidin-2-one

IUPAC name

3-[4-(furan-2-carbonyl)piperazine-1-carbonyl]piperidin-2-one

SMILES

O=C(C(CCCN1)C1=O)N(CC1)CCN1C(c1ccco1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

305.33

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

-0.589

Distribution Coefficient, logD

-0.589

Water Solubility, LogSw

-1.20

Polar Surface Area

67.194

Acid Dissociation Constant (pKa)

13.96

Base Dissociation Constant (pKb)

-1.21

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

53.30

1813-1093 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Dark Chemical Matter Library (18430 compounds)

GPCR Targeted Library (31838 compounds)

Human GPCR Annotated Library (5539 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Soluble Diversity Library (15920 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Pool
Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 1813-1093 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 1813-1093?
Check Price and Availability of 1813-1093, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 1813-1093 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 1813-1093
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 1813-1093
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 1813-1093 available by request